4.6 Article

Glimepiride Promotes Osteogenic Differentiation in Rat Osteoblasts via the PI3K/Akt/eNOS Pathway in a High Glucose Microenvironment

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

The prevalence and risk factors of vertebral fractures in Korean patients with type 2 diabetes

Dong Jin Chung et al.

JOURNAL OF BONE AND MINERAL METABOLISM (2013)

Article Biochemistry & Molecular Biology

Selective Signaling by Akt1 Controls Osteoblast Differentiation and Osteoblast-Mediated Osteoclast Development

Aditi Mukherjee et al.

MOLECULAR AND CELLULAR BIOLOGY (2012)

Review Endocrinology & Metabolism

Novel insights into the relationship between diabetes and osteoporosis

Francisco J. A. de Paula et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)

Article Endocrinology & Metabolism

Glimepiride induces proliferation and differentiation of rat osteoblasts via the PI3-kinase/Akt pathway

Pan Ma et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2010)

Article Multidisciplinary Sciences

p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner

Alina Molchadsky et al.

PLOS ONE (2008)

Article Endocrinology & Metabolism

Bone re/modeling is more dynamic in the endothelial nitric oxide synthase(-/-) mouse

F. Grassi et al.

ENDOCRINOLOGY (2006)

Article Biochemistry & Molecular Biology

Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent

B Salani et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)

Article Biochemistry & Molecular Biology

Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2

T Fujita et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2004)

Article Biochemistry & Molecular Biology

p38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose

M Zayzafoon et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)